Company page
Cantargia Ab
Cantargia Ab is a public company listed on the Swedish market under the ticker CANTA, with a market capitalization of approximately 55.9 million USD. The company focuses on developing innovative treatments for cancer and autoimmune diseases. Its research and development efforts aim to address significant medical needs in these areas.
- Ticker
- CANTA:OMXSTO
- Asset type
- Stock
- Market cap
- $55.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK